A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation

J. Chien, K. Narita, R. Rattan, S. Giri, R. Shridhar, J. Staub, D. Beleford, J. Lai, Lewis Rowland Roberts, Julian R Molina, Scott H Kaufmann, G. C. Prendergast, Vijayalakshmi Shridhar

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The pathophysiological mechanisms that drive the development and progression of epithelial ovarian cancer remain obscure. Recently, we identified TCEAL7 as a transcriptional regulatory protein often downregulated in epithelial ovarian cancer. However, the biological significance of such downregulation in cancer is not currently known. Here, we show that TCEAL7 is downregulated frequently in many human cancers and that in immortalized human ovarian epithelial cells this event promotes anchorage-independent cell growth. Mechanistic investigations revealed that TCEAL7 associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Moreover, downregulation of TCEAL7 promotes DNA-binding activity of Myc-Max, and upregulates the promoter activity of c-Myc-target gene, ornithine decarboxylase (ODC), whereas enhanced expression of TCEAL7 inhibits Myc-induced promoter activity of ODC. Our findings suggest that TCEAL7 may restrict ovarian epithelial cell transformation by limiting Myc activity. These results also suggest a potential, alternative mechanism by which c-Myc activity may be deregulated in cancer by the downregulation of TCEAL7.

Original languageEnglish (US)
Pages (from-to)7223-7234
Number of pages12
JournalOncogene
Volume27
Issue number58
DOIs
StatePublished - Dec 11 2008

Fingerprint

Cyclin D1
Tumor Suppressor Genes
Down-Regulation
Ornithine Decarboxylase
Epithelial Cells
E-Box Elements
Neoplasms
myc Genes
Up-Regulation
DNA
Growth
Proteins
Ovarian epithelial cancer

Keywords

  • Cyclin D1
  • Myc
  • TCEAL7
  • Transformation
  • Tumor suppressor

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. / Chien, J.; Narita, K.; Rattan, R.; Giri, S.; Shridhar, R.; Staub, J.; Beleford, D.; Lai, J.; Roberts, Lewis Rowland; Molina, Julian R; Kaufmann, Scott H; Prendergast, G. C.; Shridhar, Vijayalakshmi.

In: Oncogene, Vol. 27, No. 58, 11.12.2008, p. 7223-7234.

Research output: Contribution to journalArticle

Chien, J. ; Narita, K. ; Rattan, R. ; Giri, S. ; Shridhar, R. ; Staub, J. ; Beleford, D. ; Lai, J. ; Roberts, Lewis Rowland ; Molina, Julian R ; Kaufmann, Scott H ; Prendergast, G. C. ; Shridhar, Vijayalakshmi. / A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. In: Oncogene. 2008 ; Vol. 27, No. 58. pp. 7223-7234.
@article{048c942acd6b437b9c54de2ff4ce182a,
title = "A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation",
abstract = "The pathophysiological mechanisms that drive the development and progression of epithelial ovarian cancer remain obscure. Recently, we identified TCEAL7 as a transcriptional regulatory protein often downregulated in epithelial ovarian cancer. However, the biological significance of such downregulation in cancer is not currently known. Here, we show that TCEAL7 is downregulated frequently in many human cancers and that in immortalized human ovarian epithelial cells this event promotes anchorage-independent cell growth. Mechanistic investigations revealed that TCEAL7 associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Moreover, downregulation of TCEAL7 promotes DNA-binding activity of Myc-Max, and upregulates the promoter activity of c-Myc-target gene, ornithine decarboxylase (ODC), whereas enhanced expression of TCEAL7 inhibits Myc-induced promoter activity of ODC. Our findings suggest that TCEAL7 may restrict ovarian epithelial cell transformation by limiting Myc activity. These results also suggest a potential, alternative mechanism by which c-Myc activity may be deregulated in cancer by the downregulation of TCEAL7.",
keywords = "Cyclin D1, Myc, TCEAL7, Transformation, Tumor suppressor",
author = "J. Chien and K. Narita and R. Rattan and S. Giri and R. Shridhar and J. Staub and D. Beleford and J. Lai and Roberts, {Lewis Rowland} and Molina, {Julian R} and Kaufmann, {Scott H} and Prendergast, {G. C.} and Vijayalakshmi Shridhar",
year = "2008",
month = "12",
day = "11",
doi = "10.1038/onc.2008.360",
language = "English (US)",
volume = "27",
pages = "7223--7234",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "58",

}

TY - JOUR

T1 - A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation

AU - Chien, J.

AU - Narita, K.

AU - Rattan, R.

AU - Giri, S.

AU - Shridhar, R.

AU - Staub, J.

AU - Beleford, D.

AU - Lai, J.

AU - Roberts, Lewis Rowland

AU - Molina, Julian R

AU - Kaufmann, Scott H

AU - Prendergast, G. C.

AU - Shridhar, Vijayalakshmi

PY - 2008/12/11

Y1 - 2008/12/11

N2 - The pathophysiological mechanisms that drive the development and progression of epithelial ovarian cancer remain obscure. Recently, we identified TCEAL7 as a transcriptional regulatory protein often downregulated in epithelial ovarian cancer. However, the biological significance of such downregulation in cancer is not currently known. Here, we show that TCEAL7 is downregulated frequently in many human cancers and that in immortalized human ovarian epithelial cells this event promotes anchorage-independent cell growth. Mechanistic investigations revealed that TCEAL7 associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Moreover, downregulation of TCEAL7 promotes DNA-binding activity of Myc-Max, and upregulates the promoter activity of c-Myc-target gene, ornithine decarboxylase (ODC), whereas enhanced expression of TCEAL7 inhibits Myc-induced promoter activity of ODC. Our findings suggest that TCEAL7 may restrict ovarian epithelial cell transformation by limiting Myc activity. These results also suggest a potential, alternative mechanism by which c-Myc activity may be deregulated in cancer by the downregulation of TCEAL7.

AB - The pathophysiological mechanisms that drive the development and progression of epithelial ovarian cancer remain obscure. Recently, we identified TCEAL7 as a transcriptional regulatory protein often downregulated in epithelial ovarian cancer. However, the biological significance of such downregulation in cancer is not currently known. Here, we show that TCEAL7 is downregulated frequently in many human cancers and that in immortalized human ovarian epithelial cells this event promotes anchorage-independent cell growth. Mechanistic investigations revealed that TCEAL7 associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Moreover, downregulation of TCEAL7 promotes DNA-binding activity of Myc-Max, and upregulates the promoter activity of c-Myc-target gene, ornithine decarboxylase (ODC), whereas enhanced expression of TCEAL7 inhibits Myc-induced promoter activity of ODC. Our findings suggest that TCEAL7 may restrict ovarian epithelial cell transformation by limiting Myc activity. These results also suggest a potential, alternative mechanism by which c-Myc activity may be deregulated in cancer by the downregulation of TCEAL7.

KW - Cyclin D1

KW - Myc

KW - TCEAL7

KW - Transformation

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=57649121058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649121058&partnerID=8YFLogxK

U2 - 10.1038/onc.2008.360

DO - 10.1038/onc.2008.360

M3 - Article

C2 - 18806825

AN - SCOPUS:57649121058

VL - 27

SP - 7223

EP - 7234

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 58

ER -